Klapper JA - Search Results

1

Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine.

Silberstein SD, Schoenen J, Göbel H, Diener HC, Elkind AH, Klapper JA, Howard RA. Silberstein SD, et al. Among authors: klapper ja. Cephalalgia. 2009 Nov;29 Suppl 2:17-27. doi: 10.1111/j.1468-2982.2009.01974.x. Cephalalgia. 2009. PMID: 19723122 Clinical Trial.

2

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.

Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ; ONSTIM Investigators. Saper JR, et al. Cephalalgia. 2011 Feb;31(3):271-85. doi: 10.1177/0333102410381142. Epub 2010 Sep 22. Cephalalgia. 2011. PMID: 20861241 Free PMC article. Clinical Trial.

3

Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine.

Freitag FG, Cady R, DiSerio F, Elkind A, Gallagher RM, Goldstein J, Klapper JA, Rapoport AM, Sadowsky C, Saper JR, Smith TR. Freitag FG, et al. Among authors: klapper ja. Headache. 2001 Apr;41(4):391-8. doi: 10.1046/j.1526-4610.2001.111006391.x. Headache. 2001. PMID: 11318886 Clinical Trial.

4

Divalproex sodium in migraine prophylaxis: a dose-controlled study.

Klapper J. Klapper J. Cephalalgia. 1997 Apr;17(2):103-8. doi: 10.1046/j.1468-2982.1997.1702103.x. Cephalalgia. 1997. PMID: 9137847 Clinical Trial.

5

Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine.

Klapper JA, O'Connor S. Klapper JA, et al. Cephalalgia. 2000 Jul;20(6):585-7. doi: 10.1046/j.1468-2982.2000.00079.x. Cephalalgia. 2000. PMID: 11075843 Clinical Trial.

6

Efficacy of gabapentin in migraine prophylaxis.

Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, Stacey B, Tepper S. Mathew NT, et al. Headache. 2001 Feb;41(2):119-28. doi: 10.1046/j.1526-4610.2001.111006119.x. Headache. 2001. PMID: 11251695 Clinical Trial.

7

Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild.

Klapper J, Lucas C, Røsjø Ø, Charlesworth B; ZODIAC study group. Klapper J, et al. Cephalalgia. 2004 Nov;24(11):918-24. doi: 10.1111/j.1468-2982.2004.00735.x. Cephalalgia. 2004. PMID: 15482352 Clinical Trial.

8

Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine.

Gomez-Mancilla B, Cutler NR, Leibowitz MT, Spierings EL, Klapper JA, Diamond S, Goldstein J, Smith T, Couch JR, Fleishaker J, Azie N, Blunt DE. Gomez-Mancilla B, et al. Among authors: klapper ja. Cephalalgia. 2001 Sep;21(7):727-32. doi: 10.1046/j.1468-2982.2001.00208.x. Cephalalgia. 2001. PMID: 11595000 Clinical Trial.

9

Triptans in the treatment of basilar migraine and migraine with prolonged aura.

Klapper J, Mathew N, Nett R. Klapper J, et al. Headache. 2001 Nov-Dec;41(10):981-4. doi: 10.1046/j.1526-4610.2001.01192.x. Headache. 2001. PMID: 11903526

10

Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headaches.

Klapper JA, Stanton J. Klapper JA, et al. Headache. 1992 Jan;32(1):21-3. doi: 10.1111/j.1526-4610.1992.hed3201021.x. Headache. 1992. PMID: 1372884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters